Chronic stress and depression are known to reduce the number of nerve connections in the prefrontal cortex of the brain. Drugs with rapid antidepressant effects, including ketamine and classic psychedelics such as…
An extraordinary new study from a team of scientists at Yale University is reporting the first direct cellular demonstration of a single psilocybin dose inducing neural plasticity in a mammalian brain. The…
In a new study, a group of researchers led by Prof. Dr. Gerhard Gründer wants to gain robust findings on the efficacy and safety of psilocybin in the treatment of treatment-resistant major depression. Psilocybin as…
A groundbreaking British study has found that the psychedelic drug psilocybin can be safely given to patients, and may be used to treat a range of mental health conditions. Recreational use of…
Objectives of this learning scenario, developed by NYU Langone’s High School Bioethics Project, are to understand post-traumatic stress disorder (PTSD) and the symptoms it causes, learn how the chemical psilocybin, found in…
An international study led by UBC Okanagan researchers suggests repeated use of small doses of psychedelics such as psilocybin or LSD can be a valuable tool for those struggling with anxiety and…
An international study led by the University of British Columbia’s Okanagan campus suggests that repeated, small doses of psychedelic drugs can help treat some mental health issues. The research published last week found that adults who…
Chronic stress and depression can reduce the number of neuronal connections. Story at a glance Yale researchers administered a single dose of psilocybin to mice and used a laser-scanning microscope to image…
Psychedelic drug psilocybin, found in magic mushrooms, is as good at reducing symptoms of depression as conventional treatment, a small, early-stage study has suggested. But when it comes to actively improving people’s…